spacer
home > ebr > winter 2002 > stem cells find a uk niche - the uk national stem cell initiative
PUBLICATIONS
European Biopharmaceutical Review

Stem Cells Find a UK Niche - The UK National Stem Cell Initiative

Until a few years ago, stem cells were the province of developmental biologists in academic laboratories. They now represent the hottest scientific and possibly commercial property of all the life sciences. Until recently, the clinical potential of stem cells was only in the narrow field of adult haematopoiesis. Now they are heralded as a treatment for a range of intractable diseases from cancer to Alzheimer's.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Dr John Sinden, Chief Scientific Officer of ReNeuron Holdings plc John Sinden was formerly Reader in Neurobiology of Behaviour at King's College London with a special expertise in neural transplantation. With two colleagues, he founded ReNeuron in 1997, joined the company as Chief Scientific Officer in 1998 and saw the company through a successful flotation on LSE AIM in late 2000.
He is Co-ordinator on the largest EC FP5-funded stem cell grant and occasionally advises the UK Government, its agencies and the EC on scientific, industrial and ethical issues in the stem cell field.

spacer
Dr John Sinden
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

The key to tackling drug development complexity: Collaboration.

Laupheim and Ravensburg, Germany, Milford, MA, and Skokie, IL, USA, July 6, 2020 – Vetter and Rentschler Biopharma, two globally operating Contract Development and Manufacturing Organizations (CDMOs), today announced their strategic collaboration, to enhance their services and offer complementary skills and experience along the biopharmaceutical value chain. With drug development growing increasingly complex and cost-intensive, biopharmaceutical companies are under significant pressure to streamline their products’ path to market. The desired goal of the collaboration is to create long-term value through the alignment of manufacturing approaches that enable clients to bring their products to patients more easily and faster.
More info >>

White Papers
 
Industry Events

World Vaccine Congress Washington

27-29 September 2020, Walter E Washington Convention Center, Washington, US

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement